AHNS 2013 Annual Meeting - American Head and Neck Society
AHNS 2013 Annual Meeting - American Head and Neck Society
AHNS 2013 Annual Meeting - American Head and Neck Society
- No tags were found...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Scientific Program Wednesday, April 10, <strong>2013</strong>• Underst<strong>and</strong> the current prospectively obtained evidencein support of concurrent chemoradiation versusinduction chemotherapy• Be aware of the reconstructive options for recurrent/salvage surgery for recurrent oropharynx cancerThe <strong>AHNS</strong> gratefully acknowledges educational grants in supportof this panel from CelSci Corporation <strong>and</strong> OmniGuide, Inc.12:30 - 1:30 PM <strong>AHNS</strong> Business <strong>Meeting</strong> or Mediterranean 5Lunch on Own1:30 - 2:30 PM Scientific Session #2: Mediterranean 5ReconstructionModerators: Oleg Militsakh, MD <strong>and</strong> Marita S. Teng, MD1:30 PM S004: DONOR SITE MORBIDITY IN ELDERLY PATIENTS AFTERFASCIOCUTANEOUS FREE TISSUE TRANSFER. Jacob L Wester, BS,Amy Pittman, MD, Robert H Lindau, MD, Mark K Wax, MD; OregonHealth <strong>and</strong> Science University.1:38 PM S005: USE OF THE SUPRACLAVICULAR ARTERY ISLAND FLAP INHEAD AND NECK ONCOLOGIC RECONSTRUCTION: APPLICATIONSAND LIMITATIONS. Niels Kokot, MD, Grace Peng, MD, KashifMazhar, MD, Lindsay Reder, MD, Uttam K Sinha, MD; Keck School ofMedicine, University of Southern California.1:46 PM S006: DISPOSITION OF ELDERLY PATIENTS FOLLOWING HEAD ANDNECK MICROVASCULAR RECONSTRUCTION. Jeanne L Hatcher, MD,Elizabeth B Bell, BS, Joshua D Waltonen, MD; Wake Forest School ofMedicine.1:54 PM Discussion (6 minutes)2:00 PM S007: PATHOLOGICALLY DETERMINED TUMOR VOLUMEOUTPERFORMS T STAGE IN THE PREDICTION OF OUTCOMEFOLLOWING SURGICAL TREATMENT OF OROPHARYNGEALSQUAMOUS CELL CARCINOMA. Frank L Palmer, Dr. Nancy Y Lee, Dr.Ian Ganly, Dr. Iain J Nixon; Memorial Sloan Kettering Cancer Center.2:08 PM S008: USE IT OR LOSE IT: SWALLOWING EXERCISE ANDMAINTENANCE OF ORAL INTAKE DURING RADIOTHERAPY OFCHEMORADIOTHERAPY FOR OROPHARYNGEAL CANCERS.Katherine A Hutcheson, PhD, Mihir K Bhayani, MD, Beth M Beadle,MD, PhD, Kathryn A Gold, MD, Eileen H Shinn, PhD, Stephen Y Lai,MD, PhD, Jan S Lewin, PhD; The University of Texas MD AndersonCancer Center, The University of Chicago Pritzker School of Medicine.2:16 PM S009: A COMPARISON OF OUTCOMES USING IMRT AND 3DCRT INTREATMENT OF OROPHARYNGEAL CANCER. Shivangi Lohia, BA,Mayuri M Rajapurkar, MD, An<strong>and</strong> K Sharma, MD, Terry A Day, MD;Medical University of South Carolina.2:24 PM Discussion (6 minutes)The <strong>AHNS</strong> gratefully acknowledges a generous educational grantin support of this session from Stryker.Wednesday, April 10, <strong>2013</strong> Thursday, April 11, <strong>2013</strong>2:30 - 3:30 PM Panel: Current Trends Mediterranean 5in Management NMSCPanel Moderator: Cecelia Schmalbach, MD, MSThis panel will review current challenges, <strong>and</strong> provideevidence based literature, for the management of head<strong>and</strong> neck non-melanoma skin cancer (NMSC). Casebased presentations with audience participation willhighlight the management of high-risk NMSC, the role ofobservation, elective neck dissection, <strong>and</strong> sentinel nodebiopsy in the N-zero neck, the therapeutic horizons toinclude adjuvant radiation, chemotherapy <strong>and</strong> targetedagents <strong>and</strong> important considerations for successful NMSCreconstruction.April 10 - 11, <strong>2013</strong> · www.ahns.info 39
Change language